Benign liver tumors

Pre-operative radiological and clinical assessment of hepatic tumours--is biopsy necessary?

The pre-operative investigations of 72 consecutive patients who underwent liver resection for hepatic tumours have been reviewed. A combination of clinical, biochemical and radiological findings correctly predicted histology in 93% of cases (the benign or malignant nature in 97%). Biopsy was performed in only 20 patients. Five of the biopsy reports were incorrect (75% accuracy, benign or malignant nature accuracy 90%). Although guided biopsy can be performed during radiological assessment of focal hepatic lesions we argue that it is rarely indicated and can be misleading in patients proceeding to hepatic resection.

Hepatic incidentaloma: a modern problem

As clinical skills give way to increased reliance on organ imaging, a new clinical problem is identified--the hepatic "incidentaloma." This may be defined as an unexpected solid filling defect in the liver of a well patient. Thirty-six such lesions have been seen in one practice over a period of 36 months. Twenty-nine (81%) were benign: 24 (67%) nonneoplastic conditions 5 (14%) benign tumors. The remaining 7 (19%) were malignant: 5 secondary tumors and 2 primary tumors. Patients with physical signs of liver mass or enlargement were more likely to harbor malignancies. An elevated serum alkaline phosphatase (SAP) was suggestive of malignancy. Hepatic hemangioma was the most common single diagnosis (20 patients, 56%). We propose a regimen of investigation which should allow diagnosis to be reached in about one-half of these patients without admission to the hospital. The rest will need at least a short hospital admission for angiography and fine-needle aspiration biopsy.

The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia

A case of fibrolamellar hepatocellular carcinoma (FL-HCC) associated with adjacent focal nodular hyperplasia (FNH) is described. These two regions were adjacent but distinct, both on gross and microscopic examination. Currently, it is unclear whether FL-HCC rarely arises in preexisting FNH, or whether FNH is a typical response to this vascular variant of hepatocellular carcinoma (HCC). The FNH region, which is peripheral, may be biopsied to exclude the underlying carcinoma, and thus lead to inadequate therapy. Previous reports of this association are reviewed.

Mass lesions of the liver

Each of the six most common mass lesions of the liver may vary with respect to pathogenesis, clinical manifestations, natural history, usefulness of diagnostic tests, and the need for and value of surgical treatment. Despite these many variables, one broad generalization can be made: three lesions (cysts, cavernous hemangiomas, and focal nodular hyperplasia) usually are incidental findings that can be ignored, whereas three other tumors (adenomas, malignant hepatomas, and metastatic lesions) involve a threat to life that may be modified by surgical removal. This generalization, however, is not a guide to specific management because exceptions, atypical manifestations, diagnostic difficulties, and variations in the risks and limitations of surgical therapy are so common. The widespread use of new techniques for "imaging" has changed the responsibility of both the medical and the surgical hepatologist. Lessons of the past learned from the management of clinically evident symptomatic lesions have little usefulness in the management of small, "early," or indeterminate lesions. In these circumstances, physicians, surgeons, and radiologists must work in concert when a lesion is first found. Only then will clinically relevant tests be done that will ensure proper treatment of the patient.

On the pathogenesis of focal nodular hyperplasia of the liver

Fifty-one focal nodular hyperplasia lesions from 36 patients were examined histologically. Serial sections and three-dimensional models were studied in selected cases. Lesions were multiple in 19% of patients. Thirty-four patients were female. One case had 11 focal nodular hyperplasia lesions and 7 hemangiomata in the liver. Three had astrocytoma and one had anomalous pulmonary venous drainage. Morphometric analysis revealed that the lesions were supplied by an anomalous artery larger than expected for the locale in the liver. This artery branched to form a spider-like structure and was usually not accompanied by a portal vein or duct. Each terminal arterial branch supplied a separate nodule 1 mm in diameter; adjacent nodules coalesced to form the focal nodular hyperplasia lesion. The arterial blood appeared to drain directly into the sinusoids of the nodule. We propose that focal nodular hyperplasia is an hyperplastic response of the hepatic parenchyma to a preexisting arterial spider-like malformation. The frequent coexistence of focal nodular hyperplasia with other vascular and neuroendocrine anomalies suggest that the malformations are developmental in origin. The basic requirement for development of hepatic hyperplasia may be greater blood flow to a region compared to the adjacent parenchyma. This requirement appears to be met in the other forms of nodular transformation of the liver, i.e., nodular regenerative hyperplasia and partial nodular transformation.